William Born
Head of Pricing & Contracting @Kura Oncology, Inc.
Signup · Get unlimited contacts
WORK HISTORY
Head of Pricing & Contracting @Kura Oncology, Inc.
Chicago, IL, US
In my role as Head of Pricing & Contracting at Kura Oncology, Inc, I am responsible for leading the contracting and pricing functions for the launch of ziftomenib, a new oral therapy in the treatment of AML (acute myeloid leukemia). Developing launch readiness strategies and pricing models to position and support ziftomenib\'s approval.
EDUCATION
Lake Forest Graduate School of Management
MBA, Business Administration and Management, General
Eastern Illinois University
BA, Communications
SKILLS
ABOUT WILLIAM BORN
At Elevar Therapeutics, my focus was on pioneering market access channels and spearheading pricing strategies for groundbreaking therapies. Our recent work on KAMRUKA/TELVEGIO positioned it as a promising first-line combination therapy for uHCC, thanks to a well-orchestrated launch readiness plan. Previously, as Senior Director at CTI/Sobi - North America, I was instrumental in the successful market entry of VONJO®, culminating in an acquisition of $1.7 billion. This role honed my expertise in financial analytics and manufacturing process improvements, ensuring our team exceeded revenue targets and established robust market presence.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.